Compounds for the treatment of dyslipidemia and other lipid disorders

Details for Australian Patent Application No. 2005287215 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Dropinski, James F.; Zhang, Yong; Shi, Guo Q.

Agent Spruson & Ferguson

Pub. Number AU-B-2005287215

PCT Pub. Number WO2006/033891

Priority 60/610,466 16.09.04 US

Filing date 12 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 7 April 2011

International Classifications

C07D 261/20 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/033891 Priority application(s): WO2006/033891

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 April 2011 Application Accepted

  Published as AU-B-2005287215

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287216-Anti-bow roller tube arrangement

2005287214-Anti-bow roller tube housing assembly